AHK-Cu Research Overview (also known as Copper tripeptide AHK, AHK copper complex, Ala-His-Lys-Cu)
A tripeptide copper complex (Ala-His-Lys bound to Cu²⁺) naturally found in human plasma and seminal fluid. AHK-Cu promotes collagen and elastin synthesis, accelerates wound healing, stimulates hair follicle activity, and exhibits anti-inflammatory and antioxidant properties. Closely related to GHK-Cu but with a distinct tissue distribution and activity profile.
What Is AHK-Cu?
AHK-Cu is the copper complex of the tripeptide Alanine-Histidine-Lysine. Like the more widely studied GHK-Cu, AHK-Cu belongs to the family of naturally occurring copper-binding peptides found in human plasma and biological fluids. The histidine residue provides the primary copper coordination site, forming a stable chelate that both concentrates copper delivery to tissue and modulates copper's biological activity.
Relationship to GHK-Cu
AHK-Cu and GHK-Cu share mechanistic similarities — both activate collagen and elastin synthesis, promote wound repair, and exhibit anti-inflammatory activity via modulation of pro-inflammatory cytokines. AHK-Cu has been documented in seminal plasma, where it plays a role in fertility-related tissue maintenance. Some research suggests AHK-Cu may have distinct effects on hair follicle biology compared to GHK-Cu.
Hair Follicle Research
AHK-Cu has been incorporated into topical formulations studied for androgenic alopecia and hair thinning. Cell culture studies show it promotes keratinocyte proliferation and upregulates growth factors important for follicular anagen phase maintenance. It is thought to work synergistically with GHK-Cu in follicular regeneration protocols.
Skin and Wound Healing
Like GHK-Cu, AHK-Cu has demonstrated capacity to stimulate fibroblast activity, increase collagen type I and III deposition, and reduce oxidative stress markers in tissue models. Its anti-inflammatory properties include downregulation of TNF-α and IL-6 in challenged cell lines.
Quick Reference
| Literature-Reported Dose Range | 0.5-1% concentration |
| Literature-Reported Frequency | Once or twice daily |
| Literature-Reported Cycle Length | 12-24 weeks minimum, can use continuously |
| Literature-Reported Washout | Not typically needed |
| Storage | Refrigerate 2-8°C; protect from light |
| Timing | Evening preferred; avoid UV after application |
Research Indications
Hair
Hair Growth / Hair Loss
Primary research focus - stimulates hair follicle elongation and dermal papilla cell proliferation
Skin Health
Skin Regeneration
Activates fibroblasts, promotes collagen synthesis, supports wound healing
Anti-Aging
Anti-Aging
Antioxidant and anti-apoptotic effects support skin health and cellular longevity
Collagen Synthesis
Collagen Synthesis
Promotes extracellular matrix production and collagen deposition for tissue renewal
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Hair Growth | 0.5-1% topical | 1-2x daily | Scalp application |
| Skin Regeneration | 0.3-1% topical | 1-2x daily | Topical to skin |
Timing
Recommended administration window: evening preferred; avoid UV after application. Typical onset: 2-4 weeks: reduced shedding; 2-3 months: new growth; 4-6 months: significant improvement.
Peptide Interactions
Complementary copper peptides targeting different aspects of tissue regeneration. GHK-Cu excels at skin repair while AHK-Cu targets hair follicles. Can be combined in formulations
Both promote hair growth via different mechanisms - minoxidil via potassium channel opening and vasodilation, AHK-Cu via dermal papilla stimulation and VEGF. Often combined in hair loss protocols
5-alpha reductase inhibitors block DHT production while AHK-Cu may help counter DHT effects on follicles. Different mechanisms support combination approach
Risk of copper toxicity when combined with additional copper sources. Monitor total copper intake and avoid stacking copper peptides with oral copper supplements
Different tissue repair mechanisms - BPC-157 promotes systemic healing while AHK-Cu targets skin/hair. Safe to use in parallel for comprehensive regeneration support
Low pH of ascorbic acid can destabilize copper peptides. Use at different times - Vitamin C in morning, AHK-Cu in evening - to avoid interaction
Acidic exfoliants (glycolic, salicylic acid) can destabilize copper peptide complexes and reduce effectiveness. Use at different times or in separate routines
Both are potent actives that can cause irritation. Retinoids also lower skin pH. Introduce slowly or use at different times to avoid sensitization
May interfere with copper binding and reduce peptide effectiveness. Monitor for reduced efficacy if using iron-chelating compounds
Excellent combination - hyaluronic acid provides hydration and supports peptide penetration while AHK-Cu promotes follicle and skin health
Reported Research Timeline
01Week 2–4 (reported in cited studies): reduced shedding possible
02Month 2–3 (reported in cited studies): new growth visible
03Month 4–6 (reported in cited studies): significant improvement
04Month 6–12 (reported in cited studies): full results with continued use
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Avoid acidic products (AHAs, Vitamin C) - use at different times
Do not combine with copper supplements
Maintain pH 5.5-7.0 for stability
Patch test if sensitive skin
Store properly - degrades with heat/light
Seek Medical Attention If:
Persistent scalp irritation
Increased shedding beyond 6 weeks
Signs of copper sensitivity
Quality Indicators
Verified Marker
Light blue powder
Characteristic color from copper complex
Verified Marker
99%+ purity with COA
Pharmaceutical/cosmetic grade required
Quality Concern
Discolored or pH <5.0
Indicates degradation
Research Citations
- The effect of tripeptide-copper complex on human hair growth in vitro
Pyo HK, Yoo HG, Won CH, et al., 2007, Arch Pharm Res - Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A, 2018, Int J Mol Sci - Human skin penetration of a copper tripeptide in vitro as a function of skin layer
Hostynek JJ, Dreher F, Maibach HI, 2011, Inflamm Res - Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application
Ahmed S, Aljabri Z, Alharbi M, et al., 2023, Drug Deliv Transl Res - The human tri-peptide GHK and tissue remodeling
Pickart L, 2008, J Biomater Sci Polym Ed
Research Focus
Collagen synthesis, Wound healing, Hair follicle stimulation, Anti-aging, Antioxidant, Anti-inflammatory
Verified Vendors Carrying AHK-Cu
Frequently Asked Questions
What should researchers watch for with AHK-Cu?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with AHK-Cu?
Week 2–4 (reported in cited studies): reduced shedding possible
How is AHK-Cu typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →